Lasmiditan
Back to searchMolecule Structure
Scientific Name
Lasmiditan
Description of the Drug
Lasmiditan is an oral 5HT1F agonist used for the acute treatment of migraine headache with or without aura.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11732
http://www.drugbank.ca/drugs/DB11732
Brand Name(s)
Not Available
Company Owner(s)
Eli Lilly And Co
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Serotonin 1f (5-HT1f) receptor | SINGLE PROTEIN | AGONIST | CHEMBL1805 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL536057 |
| Human Metabolome Database | HMDB0304879 |
| DrugBank | DB11732 |
| PubChem: Thomson Pharma | 16713395 |
| PubChem | 11610526 |
| Nikkaji | J2.994.454G |
| PDBe | 05X |
| EPA CompTox Dashboard | DTXSID40469435 |
| DrugCentral | 5351 |
| ChemicalBook | CB72628025 |
| Guide to Pharmacology | 3928 |
| rxnorm | LASMIDITAN |
| ZINC | ZINC000003818355 |
